Forget-Me-Not Whether you believe in the metaphysical or not, there’s no denying the achievements of science. In particular, biotechnology has uncovered significant advancements in the field of medicine. For context,…
Biotech
Old Memories I have always been a sucker for nostalgia. When I first started writing for Equity Guru, I spent most of my time covering biotechnology companies. Whether they…
American Aires (WIFI.C) announced plans to expand its marketing and products into the eSports, gaming, and online streaming markets. This is an interesting left turn on behalf of this…
Spruce Biosciences Inc. (SPRB.Q) is a late-stage biopharmaceutical company developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical needs. The Company is credited for developing its…
LexaGene Holdings (LXG.V) started the new year strong by selling more of their proprietary MiQLab systems to three veterinary clinics in Michigan, Minnesota and New York. The MiQLab is…
Looking at the charts of the Psychedelics sector, they can best be described as a mixed bag. Just like Cannabis, shroom stocks are taking a hit. This could just…
Filament Health Corp. (FH.NE) announced today that it has entered into a co-development and exclusive licensing agreement with EntheoTech Bioscience Inc. “Our partnership with EntheoTech showcases our commitment to…
In this episode, we look at a life sciences instrumentation company in the genome analysis space called Bionano Genomics (BNGO.Q). The company develops and markets the Saphyr system, a…
Revive Therapeutics (RVV.C) is an interesting play. You like cannabis and its health benefits? Revive Therapeutics is one to add on your list. Maybe you are more bullish Psychedelics?…
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly,…